KUMAR AMIT

Chief Executive Officer

KUMAR AMIT has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.

On the most recent filing, KUMAR AMIT is listed as Chief Executive Officer at Anixa Biosciences Inc. Inside the rolling window, KUMAR AMIT reported 9 open-market purchases totaling $205K in ANIX and no open-market sales. The largest disclosed transaction in the window is a purchase of 21,000 ANIX shares on Jun 12, 2026, worth $53K.

Companies traded

Other insiders at ANIX

Insider Buying

$205K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ANIXPurchase$22KOct 22SEC ↗
ANIXPurchase$19KSep 28SEC ↗
ANIXPurchase$22KSep 14SEC ↗
ANIXPurchase$17KAug 3SEC ↗
ANIXPurchase$28KJul 28SEC ↗
ANIXPurchase$11KJul 27SEC ↗
ANIXPurchase$17KJul 21SEC ↗
ANIXPurchase$15KJul 13SEC ↗
ANIXPurchase$53KJun 16SEC ↗
Showing 1–9 of 9
1 / 1

Frequently asked questions

How many SEC Form 4 filings has KUMAR AMIT made?

KUMAR AMIT has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.

Which companies does KUMAR AMIT trade?

KUMAR AMIT has filed SEC Form 4 disclosures for 1 company, including ANIX.

When was KUMAR AMIT's most recent SEC Form 4 filing?

KUMAR AMIT's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.

What is KUMAR AMIT's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, KUMAR AMIT is listed as Chief Executive Officer.

What is KUMAR AMIT's total buy and sell value in the current window?

Inside the rolling retention window, KUMAR AMIT bought $205K and sold $0 based on SEC Form 4 filings.

What was KUMAR AMIT's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 21,000 ANIX shares on 2026-06-12, worth $53K, per SEC Form 4 filings.